Reaction

Stoma Site Pain reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,444 reports · 24 co-occurring drugs

As of the last recalculation, Stoma Site Pain appears in 1,444 FAERS reports alongside 24 co-occurring drug terms. The strongest observed disproportionality signal is CARBIDOPA AND LEVODOPA (PRR 110.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Carbidopa And Levodopa290110.0110.7
Teduglutide8394.194.7
Rotigotine8387.788.2
Ropinirole5856.756.9
Amantadine5856.356.5
Rivastigmine6652.953.1
Rasagiline Mesylate3445.145.2
Atropine2544.244.4
Pramipexole4240.740.8
Levodopa3340.340.4
Atropine Sulfate2533.934.0
Dimenhydrinate1723.323.3
Aprepitant2519.819.9
Oxazepam2013.613.6
Lubiprostone812.312.3
Magnesium Oxide3211.311.3
Melatonin4010.910.9
Leucovorin Calcium1410.710.7
Donepezil Hydrochloride249.69.6
Clozapine597.07.0
Trifluridine And Tipiracil45.45.4
Risankizumab-Rzaa264.64.7
Droxidopa53.33.3
Pimavanserin Tartrate123.13.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.